Oral Biotherapeutics

Injection-free Large Molecule Delivery

Rani Therapeutics has developed a novel approach for the oral delivery of large drug molecules including peptides, proteins and antibodies. We are currently in pre-clinical studies and have demonstrated greater than 50% bioavailability. View a snapshot of our results with Adalimumab and human insulin.

We are currently exploring partnerships with pharmaceutical companies. Contact us to learn more about our innovation and approach.

Mir holding Pill Capsule

From our CEO

We are tackling one of the greatest challenges in drug delivery: converting injectable drugs into pills. By replacing painful injections with pain-free pills, we have the potential to improve the quality of life for millions of patients and this is what motivates us.

  Mir Imran, Chairman & CEO